Metabonomic study of blood plasma in the assessment of liver graft function

Acta Academiae Medicinae Sinicae

Volumn 29, Issue 6, 2007, Pages 725-729

  Zhang, Qi ^a   Gao, Jing ^b   Li, Ling ^a   Chen, He Bing ^a   Li, Xin Quan ^b   Yan, Xian Zhong ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Liver transplantation; Metabonomic; Nuclear magnetic resonance; Pattern recognition

Indexed keywords

ACETONE; ALANINE; AMINO ACID; CHOLINE; GLUCOSE; GLUTAMINE; LACTIC ACID; LIPID; SUCCINIC ACID; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; METABOLOMICS; PERIOPERATIVE PERIOD; PLASMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

ACETONE; ALANINE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARCINOMA; CHOLINE; GLUTAMINE; HUMANS; LACTIC ACID; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; SUCCINIC ACID; TREATMENT OUTCOME; VALINE;

EID: 38849196879     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source.
2. Lindon JC, Holmes E, Bollard ME, et al. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis [J]. Biomarkers, 2004, 9(1):1-31.
3. Wishart DS. Metabolomics: the principles and potential applications to transplantation [J]. Am J Transplant, 2005, 5 (12):2814-2820.
4. Melendez HV, Rela M, Setchell KDR, et al. Bile acids analysis: a tool to assess graft function in human liver transplantation [J]. Transpl Int, 2004, 17(6):286-292.
5. Melendez HV, Ahmadi D, Parkes HG, et al. Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation [J]. Transplantation, 2001, 72(5):855-860.
6. 1H NMR spectroscopy in assessment of liver graft dysfunction [J]. NMR Biomed, 2003, 16(4):185-188.
7. Yang J, Zhao X, Liu X, et al. High performance liquid chromatography-mass spectrometry for metahonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B [J]. J Proteome Res, 2006, 5(3): 554-561.
8. Yang J, Xu G, Zheng Y, et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases [J]. J Chromatogr B, 2004, 813(1-2):59-65.
9. Yang J, Xu G, Hong Q, et al. Discrimination of type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles [J]. J Chromatogr B, 2004, 813(1-2):53-58.
10. Katz-Brull R, Seger D, Rivenson-Segal D, et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis [J]. Cancer Res, 2002, 62(7):1966-1970.
11. Morvan D, Demidem A, Papon J, et al. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscaopy of intact tumor samples [J]. Cancer Res, 2002, 62(6):1890-1897.
12. Herminghaus S, Pilatus U, Moller-Hartmann W, et al. Increased choline levels coincide with enhanced proliferative activity of human neuroepitheial brain tumors [J]. NMR Biomed, 2002, 15(6):385-392.
13. Holmes E, Nicholson JK, Tranter G. Metabonomic classification of genetic variations in toxicological and metabolic responses using probabilistic neural networks [J]. Chem Res Toxicol, 2001, 14(2):182-191.
14. Holmes E, Nicholls AW, Lindon JC, et al. Chemometric models for toxicity based on NMR spectra of biofluids [J] Chem Res Toxicol, 2000, 13(6):471-478.